What to learn about sildenafil in the treatment of erectile dysfunction from 3-year clinical experience

International Journal of Impotence Research

Volumn 15, Issue 6, 2003, Pages 412-417

  Jiann, B P ^a   Yu, C C ^a   Tsai, J Y ^a   Wu, T T ^a   Lee, Y H ^a   Huang, J K ^a  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Adverse effect; Erectile dysfunction; Refill rate; Response rate; Sildenafil citrate

Indexed keywords

SILDENAFIL;

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CLINICAL PRACTICE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; DIZZINESS; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DYSPEPSIA; ERECTILE DYSFUNCTION; FLUSHING; FOLLOW UP; HEADACHE; HEART PALPITATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; MYALGIA; NOSE CONGESTION; PELVIS SURGERY; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOGENIC IMPOTENCE; QUESTIONNAIRE; RETROSPECTIVE STUDY; SIDE EFFECT; TAIWAN; TELEPHONE; VISUAL IMPAIRMENT;

ADULT; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; COMORBIDITY; FOLLOW-UP STUDIES; HUMANS; IMPOTENCE; INCIDENCE; MALE; MIDDLE AGED; PIPERAZINES; PRESCRIPTIONS, DRUG; RETROSPECTIVE STUDIES; VASODILATOR AGENTS;

EID: 0345872268     PISSN: 09559930     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijir.3901047     Document Type: Article

References (22)

1. Boolell M et al. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 1996; 8: 47-52.
2. Goldstein I et al. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med 1998; 338: 1397-1404.
3. McCullough AR et al. Achieving treatment optimization with sildenafil citrate (Viagra™) in patients with erectile dysfunction. Urology 2002; 60 (Suppl 2B): 28-38.
4. Rosen RC et al. The International Index of Erectile Dysfunction (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822-830.
5. Gil A. Erectile dysfunction in a primary care setting: results of an observational, no-control-group, prospective study with sildenafil under routine conditions of use. Int J Impot Res 2001; 13: 338-347.
6. Guay AT et al. Efficacy and safety of sildenafil citrate for treatment of erectile dysfunction in a population with associated organic factors. J Androl 2001; 22: 793-797.
7. Palumbo F et al. Sildenafil: efficacy and safety in daily clinical experience. Eur Urol 2001; 40: 176-180.
8. Marks LS et al. Treatment of erectile dysfunction with sildenafil. Urology 1999; 53: 19-24.
9. McMahon CG, Samali R, Johnson H. Efficacy, safety and patient acceptance of sildenafil citrate as treatment for erectile dysfunction. J Urol 2000; 164: 1192-1196.
10. Jarow JP, Burnett AL, Geringer AM. Clinical efficacy of sildenafil citrate based on etiology and response to prior treatment. J Urol 1999; 162: 722-725.
11. Martinez-Jabaloyas JM et al. Prognostic factors for response to sildenafil in patients with erectile dysfunction. Eur Urol 2001; 40: 641-647.
12. Padma-Nathan H et al. Efficacy and safety of oral sildenafil in the treatment of erectile dysfunction: a double-blind, placebo-controlled study of 329 patients. Int J Clic Pract 1998;52: 375-380.
13. Chen KK et al. ASSESS-3: a randomized, double-blind, flexible-dose clinical trial of the efficacy and safety of oral sildenafil in the treatment of men with erectile dysfunction. Int J Impot Res 2001; 13: 221-229.
14. Wyllie MG. The phosphodiesterase inhibitor 'war'. BJU Int 2003; 91: 573-574.
15. Morales A et al. Clinical safety of oral sildenafil citrate (Viagra™) in the treatment of erectile dysfunction. Int J Impot Res 1998; 10: 69-74.
16. Wallis RM et al. Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro. Am J Cardiol 1999; 83 (Suppl 5A): 3C-12C.
17. Padma-Nathan H et al. A 4-year update on the safety of sildenafil citrate (Viagra™). Urology 2002; 60 (Suppl 2B): 67-90.
18. Moreira SG et al. Side-effect profile of sildenafil citrate (Viagra) in clinical practice. Urology 2000; 56: 474-476.
19. Huang ST. Use of sildenafil citrate in treatment of Taiwanese men with erectile dysfunction: a single center experience. Chang Gung Med J 2001; 24: 91-96.
20. DeBusk R et al. Management of sexual dysfunction in patients with cardiovascular disease: recommendations of the Princeton Consensus Panel. Am J Cardiol 2000; 86: 175-181.
21. Ishikura F et al. Effects of sildenafil citrate (Viagra) combined with nitrate on the heart. Circulation 2000; 102: 2516-2521.
22. Wysowski DK, Swann J. Use of medications for erectile dysfunction in the United States, 1996 through 2001. J Urol 2003; 169: 1040-1042.